IMPROVING THE LIVES OF INDIVIDUALS AND FAMILIES FACING HEREDITARY CANCER.
ENROLL IN RESEARCH
Use our Search and Enroll Tool to find research studies enrolling people like you.
May 02, 2022
African American Women Need to Know More About High-Risk Breast Cancer
by Felicia Johnson People of color are often at a disadvantage in the realms of education, diagnosis and treatment regarding cancer. I hope my story of BRCA1 metastatic breast cancer will help create more dialogue and more awareness so that we can...
Featured XRAY
The chance of a second breast cancer is higher among some Hawai'ian women
Women diagnosed with ductal carcinoma in situ (DCIS), an early form of breast cancer, are more likely to have a second breast cancer diagnosis if they are of Native Hawai'ian, Filipino or Japanese ancestry than...
Featured Research
PARP inhibitor (niraparib) in patients with inherited or tumor PALB2 mutations in advanced solid tumors (PAVO)
PAVO is an open-label Phase II study investigating if the study drug, a PARP inhibitor called niraparib (Zejula), is safe and effective for certain people who have been diagnosed with an advanced solid tumor with...
Meet Our Community
Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!
Be Empowered Webinar Series
Our live and on demand webinars feature presentations by experts on topics of interest and importance to our community.